AI x Bio research should not be treated as one switch, says the post
lemire · x · 2026-07-22
The post argues that treating all AI x Bio research as one capability that AI companies can simply switch on or off is a mistake.
- It says much of the relevant biodefense work is not actually dual-use.
- It argues labs can do better than a binary policy, for example by using tiered access.
- The core point is that bio-related AI governance should be more granular than a single yes/no switch.
Related event: Experts Call for Nuanced AI Biosecurity Regulations(2 posts)→
More from Safety
- Why So Many AI Researchers Think the Machines Could Kill Everyone — wiredmagazine · 2026-09-11
- California creates standards for independent AI auditors to verify lab safety testing — VraserX · 2026-09-11
- a16z podcast: why 2-3 person startups are absent from policy debates — a16z Podcast · 2026-09-11
- Researcher questions AI safety eval firm, citing 'blatantly sloppy' security and monitoring — Kyrannio · 2026-09-11
- Class action accuses Anthropic of overselling Claude subscriptions with deceptive usage multipliers — The Decoder · 2026-09-11
- MD shows buying lab media requires background checks, calling AI bioweapon doom scenarios implausible — Ghost_Pilot_MD · 2026-09-11